Phase II Trial of a GM-CSF-producing and CD40L-expressing Bystander Cell Line Combined With an Allogeneic Tumor Cell–based Vaccine for Refractory Lung Adenocarcinoma

Journal of immunotherapy (Hagerstown, Md. : 1997) - United States
doi 10.1097/cji.0b013e3182a80237
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

P3.04-27 an Allogeneic Tumor Cell Lysate Vaccine Induces Immune Responses to Lung Cancer Associated Antigens: Preliminary Results of a Phase II Study

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Phase II Trial of Methylglyoxal Bis-Guanylhydrazone (MGBG) in Refractory Small Cell Lung Cancer

Investigational New Drugs
OncologyPharmacology
1990English

Intraperitoneal Administration of a Tumor-Associated Antigen SART3, CD40L, and GM-CSF Gene-Loaded Polyplex Micelle Elicits a Vaccine Effect in Mouse Tumor Models

PLoS ONE
Multidisciplinary
2014English

Phase 1 Trial of Allogeneic Gene-Modified Tumor Cell Vaccine RCC-26/CD80/IL-2 in Patients With Metastatic Renal Cell Carcinoma

Human Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2010English

Inhaled GM-CSF in a Pulmonary Alveolar Proteinosis Patient Refractory to Plasmapheresis Combined With Multiple Whole Lung Lavages

Archives of Pulmonology and Respiratory Care
2017English

Anti-Tumor Activity of CrTX in Human Lung Adenocarcinoma Cell Line A549

Acta Pharmacologica Sinica
MedicinePharmacology
2011English

Combined Small Cell Lung Carcinoma and Adenocarcinoma With a Neuroendocrine Phenotype

Japanese Journal of Lung Cancer
OncologyRespiratory MedicinePulmonary
2009English

Anlotinib Combined With S-1 in the Third-Line Treatment of Stage IV Non-Small Cell Lung Cancer: Study Protocol for Phase II Clinical Trial

Asian Pacific Journal of Cancer Prevention
2019English

A Phase II Trial of Docetaxel and Ifosfamide for Patients With Platinum-Resistant or Refractory Non-Small Cell Lung Cancer in a Salvage Setting

Cancer Research and Treatment
Cancer ResearchOncology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy